Cenedella.de

Patient Advocate since 1977.


Leave a comment

Dr. Franjo Grotenhermen on hunger strike in solidarity with German medical marijuana patients being unable to secure medicine.

http://cannabis-hungerstreik.de/

On August 17, 2017, I entered an indefinite hunger strike. The objective of refusing to accept any food is to decriminalize all citizens who need cannabis to treat their serious diseases.

On March 10, 2017, a much-debated law on cannabis as a medicine went into effect in Germany. It was the declared aim of the legislature to allow all patients who need a therapy with cannabis medicines to do so. The law, however, proves itself in practice as bureaucratic. Therefore, a treatment with cannabis and cannabinoids is unattractive for doctors who in principle support such therapy. Many patients do not find a doctor who allows them legal access to the needed treatment.

The legislator has taken a great step into the right direction. However, many patients are still dependent on a still as illegal regarded treatment. They face criminal sanctions. This is no longer acceptable. Therefore a basic clarification in the narcotics law must be established. The prosecution of patients to whom a doctor has certified the need for a therapy with cannabis must end.

Already today, the German Narcotics Law allows prosecutors to stop a criminal case in the case of a „minor debt“. This possibility is mainly applied in cases of possession of small amounts of cannabis. I urge that criminal proceedings should in principle also be stopped if accused citizens need cannabis for medical reasons. The need for a cannabis therapy should not be judged by the judiciary, a government agency or a health insurance company, but, as with other medical treatments, also by a doctor.

I also strongly support the uncomplicated access of patients to standardized preparations from the pharmacy. In this respect, it is necessary to improve the existing law. However, the prosecution of the remaining losers of the legal situation must also be ended. I am not aware of a convincing argument by which patients‘ prosecution can be maintained. A corresponding amendment to the Narcotics Act is, therefore, logical and unavoidable.

Franjo Grotenhermen, born in 1957, studied medicine in Cologne. Medical practice in Rüthen (NRW) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is the chairman of the German Association for Cannabis as Medicine (ACM), Executive Director of the International Association for Cannabinoid Medicines (IACM) and Chairman of the Medical Cannabis Declaration (MCD), as well as author of the IACM-Bulletin, which is available in several languages ​​on the website of the IACM. Grotenhermen is an associate of the Cologne nova-Institut in the department of renewable resources and author of numerous articles and books on the therapeutic potential of cannabis and cannabinoids, their pharmaco logy and toxicology. Among others, since 2008 he has been an expert on debates in the Health Committee of the German Bundestag on the medical use of cannabis products, most recently in September 2016.

Advertisements


1 Comment

Dr. Franjo Grotenhermen, one of the world’s preeminent medical cannabis experts, has announced a hunger strike until Germany sufficiently opens up the medical cannabis program to all patients in need. –

franjo

German Cannabis Expert Announces Hunger Strike

Germany has made great strides improving its cannabis laws in recent years, but there is still so much work to be done, as too many patients are still without safe access to a safe medicine. There was understandably great hope that Germany would start treating marijuana the same as any other medicine, after the country implemented an expansion of the burgeoning medical program, but too many bureaucratic hurdles remain. Hoping to fulfill the practical notion that cannabis should be treated the same as any other prescribed medicine, Dr. Franjo Grotenhermen, on of the world’s preeminent medical cannabis experts, has announced a hunger strike until Germany sufficiently opens up the medical cannabis program to all patients in need.

I had the honor of meeting Dr. Grotenhermen when he spoke at the International Cannabis Business Conference in Berlin last year, and the man’s dedication to the cause, and expert knowledge, were evident to all in attendance. I hope when the ICBC returns to Berlin in 2018, that Dr. Grotenhermen can reflect on how his efforts have successfully brought medical cannabis fully into the medical mainstream.

Below is a press release sent out by Dr. Grotenhermen announcing his hunger strike: 

Cannabis expert starts hunger strike

Rüthen: On August 17, 2017, the German cannabis expert Franjo Grotenhermen entered an indefinite hunger strike. The objective of refusing to accept any food is to decriminalize all citizens who need cannabis to treat their serious diseases.

On March 10, 2017, a much-debated law on cannabis as a medicine went into effect in Germany. It was the declared aim of the legislature to allow all patients who need a therapy with cannabis medicines to do so. The law, however, proves itself in practice as too bureaucratic. Therefore, treatment with cannabis and cannabinoids is unattractive for doctors who in principle support such therapy. Many patients do not find a doctor who allows them legal access to the needed treatment.

“The legislature has taken a great step into the right direction,” explains Grotenhermen. “However, many patients are still dependent on a still as illegal regarded treatment. They face criminal sanctions. This is no longer acceptable. Therefore a basic clarification in the narcotics law must be established. The prosecution of patients to whom a doctor has certified the need for a therapy with cannabis must end. ”

Already today, the German Narcotics Law allows prosecutors to stop a criminal case in the case of a “minor debt”. This possibility is mainly applied in cases of possession of small amounts of cannabis. Grotenhermen urges that criminal proceedings should in principle also be stopped if accused citizens need cannabis for medical reasons. “The need for a cannabis therapy should not be judged by the judiciary, a government agency or a health insurance company, but, as with other medical treatments, also by a doctor,” explains Grotenhermen.

He also strongly supports the uncomplicated access of patients to standardized preparations from the pharmacy. In this respect, it is necessary to improve the existing law. However, the prosecution of the remaining losers of the legal situation must also be ended. “I am not aware of a convincing argument by which patients’ prosecution can be maintained,” adds Grotenhermen. A corresponding amendment to the Narcotics Act is, therefore, logical and unavoidable.

From 7 pm a 21-minute video will be presented on a special website (www.cannabis-hungerstrike.de), in which Grotenhermen explains in detail the background and goals of his hunger strike. On May 12, 2017, he had already begun a short 8-day “warning hunger strike”, by which he wanted to draw attention to a problem associated with the new law.

Franjo Grotenhermen, born in 1957, studied medicine in Cologne. Medical practice in Rüthen (NRW) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is the chairman of the German Association for Cannabis as Medicine (ACM), Executive Director of the International Association for Cannabinoid Medicines (IACM) and
Chairman of the Medical Cannabis Declaration eV (MCD), as well as author of the IACM-Bulletin, which is available in several languages on the website of the IACM. Grotenhermen is an associate of the Cologne nova-Institut in the department of renewable resources and author of numerous articles and books on the therapeutic potential of the hemp plant and cannabinoids, their pharmacology and toxicology. Among others, since 2008 he has been an expert on debates in the
Health Committee of the German Bundestag on the medical use of cannabis products, most recently in September 2016.

Anthony Johnson

Anthony, a longtime cannabis law reform advocate, was Chief Petitioner and co-author of Measure 91, Oregon’s cannabis le 

http://marijuanapolitics.com/german-cannabis-expert-announces-hunger-strike/


Leave a comment

New Book by Dr. Grotenhermen. Cannabis against cancer: The state of science and practical implications for therapy. Release Date: July 1, 2017th

by Dr. med. Franjo Grotenhermen  http://dr-grotenhermen.de/

In the past 20 years, many cellular and animal studies have been conducted to investigate which cannabinoids in which cancers are effective and could fight as cannabinoids cancer. Cannabinoids inhibit cancer growth at different levels. These include the inhibition of cancer growth through apoptosis, the suicide program of the cells, the inhibition of cancer cell proliferation, inhibition of blood vessel formation, inhibition of metastasis and the strengthening of the immune system against cancer cells.

Causation of cancer cell death and reducing cancer growth

In 2000, a research group was able to demonstrate at the Complutense University in Madrid that THC apoptosis in glioblastoma cells, very aggressive brain cancer cells caused. This was later proved to other cancers. Moreover, cannabinoids can also inhibit the growth of cancer cells in certain cancers such as melanoma, breast cancer and prostate cancer in addition to the induction of apoptosis. Remarkably, cannabinoids do not affect the viability of normal, non-transformed cells.

Interestingly, CBD that binds only weakly to cannabinoid receptors, and other cannabinoids promotes apoptosis in cancer cells. This effect is independent of CB1 and CB2 receptors. The mechanisms caused by the CBD, this effect is not yet fully understood.

Inhibition of blood vessel formation

The formation of blood vessels is critical to the growth of tumors beyond a size of 1 to 2 mm. In cancer cells, cannabinoids block the formation of new blood vessels in which they inhibit a specific growth factor (vascular endothelial growth factor). This and other mechanisms cause the vessel formation in tumors normalized. It will then be smaller and less blood vessels produced. Besides THC and CBD, a number of synthetic cannabinoids inhibit the formation of blood vessels in animal experiments with various types of cancer.

Inhibition of metastasis

The activation of CB1 or CB2 receptor agonists (or both) also reduces the formation of secondary tumors (metastases) in animal models. This includes support for the migration ability (migration) of cancer cells, their ability to attach to other tissues (adhesion) and their ability to penetrate tissue (invasion), inhibited. This has been demonstrated for glioblastoma cells, breast, lung, and cervical cancer cells in cultures.

in various animal models of cancer also CBD, which acts independently of CB1 and CB2 receptors, has the ability to inhibit metastasis. An important role in metastasis plays the inhibition of DNA binding, so-called Ids. In one study, incubation of breast cancer cells to CBD led to a reduction of Id-1, which inhibited their invasiveness.

Regulation of anti-tumor immunity

 

The activation of cannabinoid receptors may lead to changes in the immune system to fight cancer. These changes are called especially the increased production of anti-inflammatory messenger substances (cytokines) in the immune system and the increased formation of regulatory T cells, and suppressor T cells. Regulatory T cells are important for the suppression of unwanted immune processes. They therefore protect against autoimmune diseases and may otherwise be used by tumor cells to escape attacks the immune system. Therefore, there are reports of tumor formation was promoted by the activation of CB2 receptors in which the tumor monitoring has been impaired by the immune system.

On the other hand cannabinoids can also improve the tumor surveillance by the immune system under certain conditions. Thus, the antitumor effect of cannabinoids through the activation of CB2 receptors against melanoma in mice with normal immune systems in a study for example, was stronger than in mice with suppressed immune systems. So cannabinoids can be successfully used against cancer, the tumor-inhibiting effects must be stronger than the immune-suppressive and tumor growth potentially promoting effects.

Detailed information: New Book by Dr. Grotenhermen. Cannabis against cancer: The state of science and practical implications for therapy. Release Date: July 1, 2017th


Leave a comment

Dr. Franjo Grotenhermen – HERO!

Solidarity for abandoned cannabis patients.

Dr. med. Franjo Grotenhermen Employee of the nova Institute, Chairman of the Cannabis Association as Medicine (ACM)
Dr. med. Franjo Grotenhermen, photo: Archive

 

The well-known physician and chairman of the Cannabis Association as a medicine (ACM) Dr. Franjo Grotenhermen has made a moving decision. Although certain positive aspects could be felt in parts through the enacted cannabis-as-medicine law, there would be enough problems in the entire treatment area, which now led to a drastic measure. During the ACM Annual General Meeting in Frankfurt on May 12, 2017, the medical doctor, who has been advocating medical medicine for many years, declares his decision not to eat any food for the next one to two weeks as a result of solidarity with the many cannabis patients left alone.
Doctor Franjo Grotenhermen joins the hunger strike.

 


Dr. Franjo Grotenhermen at the ACM Annual General Meeting 2017 explains hunger strike.

 

The drug policy speakers of the parties were informed before Dr. Franjo Grotenhermen of the warnings – an honorary man.